Delivery Order SPE2DB20D3303-SPE2DB25FA1ZA
- Not listed
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,439.96 firm fixed-price contract is for the supply of 4566932081 - Brimonidine Tartrate 0.15% Ophthalmic Drops, 10 mL. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,956,051 units of Brimonidine Tartrate 0.15% eye drop solution in 10 mL bottles. The $1,557.50 contract has a performance period through March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor, providing pharmaceutical and medical supply distribution services to the Department of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Brimonidine Tartrate 0.15% eye drops, a medication used to treat glaucoma. The contract has a ceiling value of $6,782.94 and a completion date of July 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,883.20 Firm Fixed Price Delivery Order covers the supply of Brimonidine Tartrate 0.15% eye drops, a medication used to treat glaucoma. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,892.12 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Brimonidine 0.33% gel pump in 30-gram units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 24, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania location. Brimonidine is an alpha-adrenergic agonist commonly used in ophthalmology for treating glaucoma and ocular hypertension,...
- This federal contract award is for the delivery of Brimonidine Tartrate 0.1% eye drops in a 5mL volume. The award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price of $1,170.00 and a completion date of November 7, 2024. The awardee is not subject to any set-aside requirements. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award is for the delivery of Brimonidine Tartrate 0.15% eye drops in 15mL bottles to the Defense Logistics Agency (DLA). The $1,451.83 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 24, 2021. The contract has an ultimate completion date of September 27, 2021 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent...
- The Defense Logistics Agency awarded a $251 firm fixed price delivery order to Amerisourcebergen Drug Corporation for brimonidine 0.2% eye drops. As the prime contractor, Amerisourcebergen will supply 10mL bottles of the eye drops to meet DLA requirements. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period from July 7 to July 10, 2023. No subcontractors or set aside designations were identified. The delivery order was issued under...
- The Defense Logistics Agency awarded a $104,090 delivery order to Amerisourcebergen Drug Corporation for the supply of 5ml bottles of 0.2% brimonidine eye drops. The contract has a firm fixed price and will be performed in Conshohocken, Pennsylvania over a one day period from June 26-27, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this award supports the DLA's logistical needs by ensuring the availability of brimonidine, a medication...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,045 to Amerisourcebergen Drug Corporation for brimonidine tartrate 0.15% ophthalmic solution. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. The single day order is scheduled to be completed by August 30, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order without the use of...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1ZADelivery Order
The Defense Logistics Agency awarded a $1,960.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.1% ophthalmic drops (5mL) with an ultimate completion date of July 31, 2025. This delivery order, issued on July 30, 2025, is classified as a child contract and was awarded without a set-aside designation through competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Brimonidine Tartrate is a selective alpha-2 adrenergic agonist used primarily to treat open-angle glaucoma and ocular hypertension, representing a critical pharmaceutical supply for military and veteran healthcare systems supported by DLA. This delivery order is issued under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to Defense Health Agency and other federal healthcare systems worldwide. The company's extensive portfolio of federal contract awards demonstrates its capability as a major pharmaceutical distributor and established critical vendor for federal medical procurement, with delivery orders typically structured as firm fixed-price transactions across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/30/25 |